Challenges in diabetic foot treatment during pandemic of COVID-19

References

1. 1.↵
   Institute for Public Health FB&H. Health condition of the population and health care in the Federation of the Bosnia and Herzegovina. [Updated: 2017. Accessed 2021 January 20] Available from URL: https://www.zzjzfbih.ba/wp-content/uploads/2018/10/Zdravstveno-2017.pdf
2. 2.↵
   1. Zhang P,
   2. Lu J,
   3. Jing Y,
   4. Tang S,
   5. Zhu D,
   6. Bi Y.

   Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med 2017; 49: 106-116.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Mishra SC,
   2. Chhatbar KC,
   3. Kashikar A,
   4. Mehndiratta A.

   Diabetic foot. BMJ 2017; 359: j5064.

   OpenUrlFREE Full Text
4. 4.↵
   1. Ţânţu MM,
   2. Man GM,
   3. Rogozea LM,
   4. Domnariu CD,
   5. Pleşa FC,
   6. Traşcă DM, et al.

   Diabetic foot-epidemiological and histopathological aspects. Rom J Morphol Embryol 2018; 59: 895-902.

   OpenUrl
5. 5.↵
   1. Ten Hoope W,
   2. Looije M,
   3. Lirk P.

   Regional anesthesia in diabetic peripheral neuropathy. Curr Opin Anaesthesiol 2017; 30: 627-631.

   OpenUrl
6. 6.↵
   1. Yu ZY,
   2. Geng J,
   3. Li ZQ,
   4. Sun YB,
   5. Wang SL,
   6. Masters J, et al.

   Dexmedetomidine enhances ropivacaine-induced sciatic nerve injury in diabetic rats. Br J Anaesth 2019; 122: 141-149.

   OpenUrl
7. 7.↵
   1. Zhang JX,
   2. Gray J,
   3. Lalonde DH,
   4. Carr N.

   Digital necrosis after lidocaine and epinephrine injection in the flexor tendon sheath without phentolamine rescue. J Hand Surg Am 2017; 42: e119-e123.

   OpenUrlCrossRef